Video interview with Tim Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute and an American Society of Nuclear Cardiology (ASNC) past-president, explaining the role of SPECT into the future as PET becomes more popular. A new look at PET vs SPECT.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

Novosound ultrasound wearable

The patent is the Scottish tech company's 21st earned since 2018.

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

The program is a simplified modification of the popular Mirai deep-learning algorithm, developed by researchers at MIT to predict future cancer.

IVUS with coregistration with angiography displayed by Philips at TCT 2023. Photo by Dave Fornell

Eric Secemsky, MD, from Beth Israel Deaconess Medical Center and Harvard Medical School, says a lack of hands-on training and reimbursement challenges are hindering the adoption of IVUS.

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.